Dark

ABBV
ABBVIE INC.
stock NYSE

At Close

May 8, 2026 3:59:59 PM EDT

201.40USD-0.644%(-1.31)4,915,719

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 7, 2026 8:57:22 AM EDT

204.92USD+1.090%(+2.21)0

After-hours

May 6, 2026 4:25:04 PM EDT

204.95USD-0.049%(-0.10)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

356.33B

CEO

Richard Gonzalez

Headquarters

North Chicago, Illinois, USA

Industry

Drug Manufacturers-General

Last Dividend

Apr 15, 20251.640

AMGN NBIX GILD BIIB AZN GSK BMY LLY PFE XLV

ABBV Stats

Avg. Vol. 10 Day

6,880,505

Avg. Vol. 30 Day

6,647,966

Employees

30,000

Market Cap

356,334,868,470

Shares Out.

1,768,762,377

On/Off Exchange

51%/49%

6 Month Beta

0.24

1 Year Beta

0.27

2 Year Beta

0.33

3 Year Beta

0.33

52 Week Low

176.57

52 Week High

244.81

SMA50

212.32

SMA200

218.33

1 Week

-2.49%

1 Month

-5.15%

3 Month

-9.76%

6 Month

-7.89%

1 Year

+9.13%

2 Year

+25.60%

5 Year

+73.34%

Profile

AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.

ABBV Stock Summary

ABBVIE INC. (NYSE:ABBV) stock price today is $201.40, and today's volume is 4,915,719. ABBV is down -0.644% today. The 30 day average volume is 6,647,966. ABBV market cap is 356.33B with 1,768,762,377 shares outstanding.

document.getElementById("zL14zZ").onerror = function(){this.style.display='none';}; .dark-mode .dyh2Zj{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .dyh2Zj{ color: #333333; background-color: white; border: 2px solid #333333; }ABBVABBVIE INC.stock NYSE

ABBV Stock Summary

ABBV
ABBVIE INC.
stock NYSE